• T. F. Zuck
  • C. Dudok de Wit
Part of the Developments in Hematology and Immunology book series (DIHI, volume 27)


T.F. Zuck (Cincinnati, OH, USA): Prof. Gevers, you talked about the use of the word commercialization several times. At least in our country it is a major issue to define what commercialization is. Does it relate to the plasma fractionation industry, does it relate to a non-for-profit blood centre that “makes money” — has excess of revenue over expense. Could you share with us your view of what a commercial enterprise in blood, blood components and fractionated blood products is?


Blood Bank Blood Centre Plasma Product Donor Selection Viral Inactivation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science+Business Media Dordrecht 1992

Authors and Affiliations

  • T. F. Zuck
  • C. Dudok de Wit

There are no affiliations available

Personalised recommendations